Results 21 to 30 of about 302,208 (172)

The gamble between oncolytic virus therapy and IFN

open access: yesFrontiers in Immunology, 2022
Various studies are being conducted on oncolytic virotherapy which one of the mechanisms is mediating interferon (IFN) production by it exerts antitumor effects.
Qingbo Li   +10 more
doaj   +1 more source

Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches

open access: yesPharmaceutics, 2022
Oncolytic virotherapy is a type of nanomedicine with a dual antitumor mechanism. Viruses are engineered to selectively infect and lyse cancer cells directly, leading to the release of soluble antigens which induce systemic antitumor immunity ...
Qing Ji   +4 more
doaj   +1 more source

Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes

open access: yesViruses, 2021
Recent cancer immunotherapy breakthroughs have fundamentally changed oncology and revived the fading hope for a cancer cure. The immune checkpoint inhibitors (ICI) became an indispensable tool for the treatment of many malignant tumors.
Alexander Malogolovkin   +5 more
doaj   +1 more source

Future Application of Oncolytic Viruses for Cancer Treatment [PDF]

open access: yes, 2023
Cancer treatments have developed over the years. A particular improvement is the utilization of oncolytic viruses to treat cancers. Oncolytic viruses are one of the immunotherapeutic tools that potentially could provide good results and benefits to the ...
Jo, Juandy   +3 more
core   +1 more source

Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect [PDF]

open access: yes, 2017
: With the advancement of a growing number of oncolytic viruses (OVs) to clinical development, drug delivery is becoming an important barrier to overcome for optimal therapeutic benefits.

core   +1 more source

Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles [PDF]

open access: yes, 2010
Targeted therapy of cancer using oncolytic viruses has generated much interest over the past few years in the light of the limited efficacy and side effects of standard cancer therapeutics for advanced disease.
Wang, YH   +5 more
core   +1 more source

Recent advances in oncolytic virus therapy for hepatocellular carcinoma

open access: yesFrontiers in Oncology, 2023
Hepatocellular carcinoma (HCC) is a highly refractory cancer and the fourth leading cause of cancer-related mortality worldwide. Despite the development of a detailed treatment strategy for HCC, the survival rate remains unsatisfactory.
Licheng Zhu   +14 more
doaj   +1 more source

Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy

open access: yes, 2022
Oncolytic viruses are highly promising for cancer treatment because they target and lyse tumor cells. These genetically engineered vectors introduce therapeutic or immunostimulatory genes into the tumor.
Dymova, Maya A.   +7 more
core   +1 more source

The role of autophagy in neoplastic cell response to oncolytic viruses [PDF]

open access: yes, 2009
Oncolytic conditionally replicating adenoviruses (CRAds) are viral mutants able to selectively replicate in tumour cells. CRAds are considered a promising platform for cancer therapy. dl922-947, bearing a mutation in E1A gene and AdΔΔ, carrying mutations
Botta, Ginevra
core   +1 more source

Assessment and development of adenovirus type 11 for cancer therapy [PDF]

open access: yes, 2010
PhDThe efficacy of oncolytic virotherapy is influenced by the interactions between the tumour, virus and host immunity. The first generation of oncolytic adenoviruses, based on serotype 5 (Ad5), has achieved limited success in clinical trials.
Wong, Han Hsi
core   +3 more sources

Home - About - Disclaimer - Privacy